
Service Area
U.S. FDA Agent
U.S. Agent services to support FDA registration, device listing, and compliance for non-U.S. medical device and IVD manufacturers.
U.S. FDA Agent
When is a U.S. FDA Agent required?
The Federal Drug Administration (FDA) requires a U.S. Agent for foreign establishments that manufacture, prepare, or process devices imported into the United States. The US Agent must reside in the United States and be available to answer questions from the FDA during business hours. An Official Correspondent is designated as the individual responsible for maintaining the registration and device listing account during registration. Qserve acts as the U.S. Agent and the Official Correspondent for establishments registered with the FDA.

US Agent vs. Official Correspondent
For non-US medical device and IVD manufacturers, both a US Agent and an Official Correspondent are required under FDA regulations. While their roles are complementary, they have distinct responsibilities.
Get in touch for more information about US FDA Agent services
Responsibilities of the US Agent
The US Agent acts as the FDA’s point of contact within the United States. This role includes: Assisting the FDA in communication with the foreign establishment. Responding to questions about the manufacturer’s devices being imported into the US. Assisting the FDA in scheduling inspections of the foreign establishment. The US Agent must be physically located in the United States and listed in the FDA’s FURLS system during registration.
Role of the Official Correspondent
The Official Correspondent is responsible for administrative tasks related to the FDA registration process. This includes: Managing the establishment’s registration and device listing accounts in the FDA’s FURLS system. Handling the annual renewal of establishment registration. Receiving all FDA correspondence related to registration and listing. Unlike the US Agent, the Official Correspondent does not need to be based in the US, but often works closely with the US Agent to maintain compliance.
Blogs
Latest blogs
.png)
The new QMSR era: FDA inspections move from procedural QSIT audits to risk‑driven, lifecycle‑focused, ISO‑aligned regulatory examinations.

With February 2, 2026 fast approaching, read how to prepare for the FDA QMSR under ISO 13485 based on your current Quality Management System.

Working with the right partner can make a critical difference in bringing medical devices to American patients and healthcare providers.